MetLife Investment Management’s Patterson-UTI PTEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.02M | Sell |
186,118
-3,971
| -2% | -$34K | 0.01% | 1052 |
|
|
2025
Q4 | $1.16M | Sell |
190,089
-15,230
| -7% | -$90.9K | 0.01% | 1338 |
|
|
2025
Q3 | $1.06M | Sell |
205,319
-4,680
| -2% | -$26.9K | 0.01% | 1408 |
|
|
2025
Q2 | $1.25M | Sell |
209,999
-964,960
| -82% | -$5.81M | 0.01% | 1199 |
|
|
2025
Q1 | $9.66M | Buy |
1,174,959
+942,400
| +405% | +$7.91M | 0.05% | 347 |
|
|
2024
Q4 | $1.92M | Buy |
232,559
+11,551
| +5% | +$92.7K | 0.01% | 1067 |
|
|
2024
Q3 | $1.69M | Sell |
221,008
-9,331
| -4% | -$86K | 0.01% | 1110 |
|
|
2024
Q2 | $2.39M | Buy |
230,339
+48,103
| +26% | +$527K | 0.01% | 887 |
|
|
2024
Q1 | $2.18M | Sell |
182,236
-3,570
| -2% | -$39.7K | 0.01% | 916 |
|
|
2023
Q4 | $2.01M | Sell |
185,806
-1
| -0% | -$12 | 0.01% | 942 |
|
|
2023
Q3 | $2.57M | Buy |
185,807
+74,072
| +66% | +$1.08M | 0.02% | 787 |
|
|
2023
Q2 | $1.34M | Hold |
111,735
| – | – | 0.01% | 1112 |
|
|
2023
Q1 | $1.31M | Hold |
111,735
| – | – | 0.01% | 1088 |
|
|
2022
Q4 | $1.88M | Sell |
111,735
-124,439
| -53% | -$2.05M | 0.01% | 931 |
|
|
2022
Q3 | $2.76M | Buy |
236,174
+239
| +0.1% | +$3.42K | 0.02% | 730 |
|
|
2022
Q2 | $3.72M | Buy |
235,935
+12,896
| +6% | +$217K | 0.03% | 605 |
|
|
2022
Q1 | $3.45M | Buy |
223,039
+30,250
| +16% | +$382K | 0.02% | 748 |
|
|
2021
Q4 | $1.63M | Hold |
192,789
| – | – | 0.01% | 941 |
|
|
2021
Q3 | $1.74M | Hold |
192,789
| – | – | 0.02% | 922 |
|
|
2021
Q2 | $1.92M | Hold |
192,789
| – | – | 0.02% | 898 |
|
|
2021
Q1 | $1.37M | Sell |
192,789
-16,754
| -8% | -$118K | 0.01% | 992 |
|
|
2020
Q4 | $1.1M | Hold |
209,543
| – | – | 0.01% | 1086 |
|
|
2020
Q3 | $597K | Hold |
209,543
| – | – | 0.01% | 1279 |
|
|
2020
Q2 | $727K | Sell |
209,543
-26,568
| -11% | -$91.6K | 0.01% | 1178 |
|
|
2020
Q1 | $555K | Hold |
236,111
| – | – | 0.01% | 1158 |
|
|
2019
Q4 | $2.48M | Sell |
236,111
-6,173
| -3% | -$55.9K | 0.03% | 718 |
|
|
2019
Q3 | $2.07M | Sell |
242,284
-5,711
| -2% | -$56K | 0.02% | 774 |
|
|
2019
Q2 | $2.85M | Sell |
247,995
-6,687
| -3% | -$86.1K | 0.03% | 642 |
|
|
2019
Q1 | $3.57M | Sell |
254,682
-2,329
| -0.9% | -$30.5K | 0.04% | 520 |
|
|
2018
Q4 | $2.66M | Sell |
257,011
-2,138
| -0.8% | -$31.5K | 0.03% | 621 |
|
|
2018
Q3 | $4.43M | Buy |
259,149
+100,302
| +63% | +$1.72M | 0.05% | 419 |
|
|
2018
Q2 | $2.86M | Buy |
158,847
+686
| +0.4% | +$13.8K | 0.03% | 644 |
|
|
2018
Q1 | $2.77M | Sell |
158,161
-2,021
| -1% | -$42.2K | 0.03% | 646 |
|
|
2017
Q4 | $3.69M | Buy |
+160,182
| New | +$3.32M | 0.04% | 513 |
|
Other funds holding PTEN
VPM
VCM
SG
MetLife Investment Management's PTEN Position: Q1 2026 in Review
MetLife Investment Management reduced its Patterson-UTI (PTEN) stake by 2.1% in Q1 2026, selling an estimated $34K and leaving 186,118 shares worth $2.02M. The position accounts for 0.01% of the portfolio, ranked #1052.
MetLife Investment Management first reported a position in PTEN in Q4 2017 and has held it in 34 quarters since. The position peaked at $9.66M in Q1 2025. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.
- MetLife Investment Management held 186,118 shares of Patterson-UTI worth $2.02M as of Q1 2026.
- MetLife Investment Management sold 3,971 Patterson-UTI shares in Q1 2026, an estimated $34K.
- Patterson-UTI made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1052 holding.
- MetLife Investment Management first reported a position in Patterson-UTI in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Patterson-UTI position peaked at $9.66M in Q1 2025.
- 410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.